Complete AI committee score history · 2 sessions recorded · Updated nightly
| Date | Score | Rating | Recommendation | Conviction | Agreement | Analysts |
|---|---|---|---|---|---|---|
| 2026-07-11 | 62.8 | Buy | Buy | Contested | 50% | 6 |
| 2026-07-10 | 60.9 | Buy | Buy | Contested | 71% | 7 |
About This Data
Committee scores are generated nightly by Innellis's 6-analyst AI committee. Each session analysts independently score Eli Lilly and Company across fundamentals, momentum, and risk — then debate and reach a consensus. Scores range from 0 (most bearish) to 100 (most bullish). View track record →